Breast Cancer
Long term breast-conservation treatment and invasive treatments compared
Published in Cancer Weekly, September 6th, 2005
"The objective of a current study" by researchers at the University of Pennsylvania "was to determine the long-term results of breast-conservation treatment in women with early-stage, invasive lobular carcinoma of the breast. Between 1977 and 1995, 1093 women with Stage I and II invasive ductal carcinoma of the breast and 55 women with invasive lobular carcinoma of the breast underwent lumpectomy, axillary lymph node dissection, and radiation treatment."
"Overall, 49% of the women received adjuvant systemic therapy (chemotherapy and/or hormones),"...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2005-09-06)
More Articles from Cancer Weekly
- Head & Neck Cancer
Increased mtDNA content in saliva associated with head and neck cancer - Lymphoma
Lack of SmIg light chain expression by B-cells did not always indicate lymphoma - Patient Consultation
Physician sitting v. standing during inpatient oncology consultations compared - Prostate Cancer
Sun exposure and VDR gene polymorphisms linked to risk of prostate cancer - Skin Cancer
Perception of importance of skin cancer assessed - Acute Myeloid Leukemia
AML bearing cytoplasmic nucleophosmin showed distinct gene expression profile - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
